---
title: "(Safety) Safety Measures - PMDA-ATC E-learning"
image: "https:\/\/i.ytimg.com\/vi\/1xS3UZtZtpg\/hqdefault.jpg"
vid_id: "1xS3UZtZtpg"
categories: "Nonprofits-Activism"
tags: ["PMDA","safety","pharmacovigilance"]
date: "2022-05-08T06:11:59+03:00"
vid_date: "2021-04-01T00:00:00Z"
duration: "PT4M14S"
viewcount: "557"
likeCount: ""
dislikeCount: ""
channel: "Pmda Channel"
---
{% raw %}In any pharmaceutical product, there always lies the possibility of unexpected adverse reactions surfacing after approval, because there is insufficient safety evidence when a new drug is approved.This video provides an introduction to how adverse drug reactions and infections reports are dealt with between the Marketing Authorization Holder, PMDA and the Ministry of Health, Labour and Welfare, and the current regulatory framework for drug post-marketing surveillance in Japan.{% endraw %}
